These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2887085)

  • 21. Significance of reduction in heart rate in cardiovascular disease.
    Hjalmarson A
    Clin Cardiol; 1998 Dec; 21(12 Suppl 2):II3-7. PubMed ID: 9853192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium channel blockers: rationale for their clinical use.
    Conti CR
    J Fla Med Assoc; 1981 Nov; 68(11):883-6. PubMed ID: 6120992
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
    Lee L; Horowitz J; Frenneaux M
    Eur Heart J; 2004 Apr; 25(8):634-41. PubMed ID: 15084367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current classification of anti-arrhythmia agents].
    Weirich J; Wenzel W
    Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects of calcium channel blocking agents and varying extracellular calcium concentration on hypoxia/reoxygenation and ischemia/reperfusion-induced cardiac injury.
    Fitzpatrick DB; Karmazyn M
    J Pharmacol Exp Ther; 1984 Mar; 228(3):761-8. PubMed ID: 6707924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-blockers as antiarrhythmic agents.
    Zicha S; Tsuji Y; Shiroshita-Takeshita A; Nattel S
    Handb Exp Pharmacol; 2006; (171):235-66. PubMed ID: 16610347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of medications on myocardial perfusion.
    Zoghbi GJ; Dorfman TA; Iskandrian AE
    J Am Coll Cardiol; 2008 Aug; 52(6):401-16. PubMed ID: 18672159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of antianginal drugs on ventricular function, myocardial blood flow and peripheral circulation.
    Banka VS; Bodenheimer MM; Helfant RH
    Herz; 1982 Dec; 7(6):366-77. PubMed ID: 6131025
    [No Abstract]   [Full Text] [Related]  

  • 29. Calcium channel blockers, beta blockers and the maintenance of calcium homeostasis.
    Nayler WG; Sturrock WJ
    Adv Exp Med Biol; 1986; 194():535-56. PubMed ID: 2875627
    [No Abstract]   [Full Text] [Related]  

  • 30. [Preconditioning of the ischemic myocardium].
    Tedesco MA; Ratti G; Aquino D; Iacono A
    Cardiologia; 1995 Jan; 40(1):51-9. PubMed ID: 8529240
    [No Abstract]   [Full Text] [Related]  

  • 31. Advances in cardiovascular pharmacology.
    Goldberg LI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 6():S922-7. PubMed ID: 6084150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Glucose-insulin-potassium (GIK) solution: cardioprotective effects of insulin].
    Rojas Pérez EM; Luna Ortiz P; Serrano Valdez X; Fernández Rivera BJ; de Micheli A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S144-51. PubMed ID: 17469342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-calcium effects of 4-hydroxypropiophenone derivatives--potential beta-adrenoreceptor blockers].
    Cizmáriková R; Kozlovský J
    Ceska Slov Farm; 1994 Oct; 43(5):226-8. PubMed ID: 7982006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial protection of insulin and potassium in a porcine ischemia-reperfusion model.
    Oates A; Nubani R; Smiley J; Kistler L; Hughey S; Theiss P; Perez-Tamayo RA; Eiferman D; Lonchyna V; Higgins RS
    Surgery; 2009 Jul; 146(1):23-30. PubMed ID: 19541007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effects of antihypertensive drugs on lipid metabolism. Part I. Diuretics, beta-blockers, calcium antagonists].
    Martynov AI; Ostroumova OD; Mamaev VI; Rybkina TE; Kuznetsov VI; Tikhonova LIa; Smirnova MV
    Klin Med (Mosk); 2001; 79(8):8-12. PubMed ID: 11588795
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Beta blockers in stable angina pectoris].
    Fluri M; Meier B
    Praxis (Bern 1994); 1995 Mar; 84(10):288-95. PubMed ID: 7892549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The influence of a beta-adrenergic receptor blocking drug and a calcium antagonist on heart function in normal subjects (author's transl)].
    Wink K; Schalk T
    Arzneimittelforschung; 1981; 31(9):1474-8. PubMed ID: 6118163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperinsulinemia, insulin resistance, and hypertension.
    Bönner G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.